Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

An in vivo study comparing efficacy of 0.25% and 0.5% bupivacaine in infraorbital nerve block for postoperative analgesia

  • Saha, Aditi (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth) ;
  • Shah, Sonal (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth) ;
  • Waknis, Pushkar (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth) ;
  • Aher, Sharvika (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth) ;
  • Bhujbal, Prathamesh (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth) ;
  • Vaswani, Vibha (Department of Oral and Maxillofacial Surgery, Dr. D.Y. Patil Vidyapeeth)
  • Received : 2019.01.07
  • Accepted : 2019.03.07
  • Published : 2019.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Pain is an unpleasant sensation ranging from mild localized discomfort to agony and is one of the most commonly experienced symptoms in oral surgery. Usually, local anesthetic agents and analgesics are used for pain control in oral surgical procedures. Local anesthetic agents including lignocaine and bupivacaine are routinely used in varying concentrations. The present study was designed to evaluate and compare the efficacy of 0.25% and 0.5% bupivacaine for postoperative analgesia in infraorbital nerve block. Methods: Forty-one patients undergoing bilateral maxillary orthodontic extraction received 0.5% bupivacaine (n = 41) on one side and 0.25% bupivacaine (n = 41) on the other side at an interval of 7 d. The parameters evaluated for both the bupivacaine concentrations were onset of action, pain during procedure (visual analog scale score [VAS]), and duration of action. The results were noted, tabulated, and analyzed using the Wilcoxon signed rank test. Results: The onset of action of 0.5% bupivacaine was quicker than that of 0.25% bupivacaine, but the difference was not statistically significant (P = 0.306). No significant difference was found between the solutions for VAS scores (P = 0.221) scores and duration of action (P = 0.662). Conclusion: There was no significant difference between 0.25% bupivacaine and 0.5% bupivacaine in terms of onset of action, pain during procedure, and duration of action. The use of 0.25% bupivacaine is recommended.

Keywords

References

  1. Mishra A, Mahajan M, Bande C, Joshi A, Gawande M, Gupta MK. Is amalgamated ligno-bupivacaine an answer to complicated minor oral surgical anesthesia? A randomized split-mouth double-blind clinical trial. Oral Maxillofac Surg 2018; 22: 97-104. https://doi.org/10.1007/s10006-018-0676-z
  2. Ekenstam B Af, Egner B, Pettersson G. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic acid amides. Acta Chem Scand 1957; 11: 1183-90. https://doi.org/10.3891/acta.chem.scand.11-1183
  3. Chapman PJ. A controlled comparison of effectiveness of bupivacaine for post-operative pain control. Aust Dent J 1988; 33: 288-90. https://doi.org/10.1111/j.1834-7819.1988.tb04178.x
  4. Malamed SF. Handbook of local anesthesia. 5th ed. St. Louis, Mosby, 2004; 73-4.
  5. Chapman PJ, Macleod AW. A Clinical Study of Bupivacaine for Mandibular Anesthesia in Oral Surgery. Anesth Prog 1985; 32: 69-72.
  6. Monheim, Leonard M., Bennett CR. Monheim's Local Anesthesia and Pain Control in Dental Practice. 7th ed. St. Louis: Mosby, 1984; 154-6.
  7. Thakare A, Bhate K, Kathariya R. Comparison of 4% articaine and 0.5% bupivacaine anesthetic efficacy in orthodontic extractions: prospective, randomized crossover study. Acta Anaesthesiol Taiwan 2014; 52: 59-63. https://doi.org/10.1016/j.aat.2014.04.006
  8. Moradi S, Naghavi N. Comparison of bupivacaine and lidocaine use for postoperative pain control in endodontics. Iran Endod J 2010; 5: 31-5.
  9. Su N, Wang H, Zhang S, Liao S, Yang S, Huang Y. Efficacy and safety of bupivacaine versus lidocaine in dental treatments: a meta-analysis of randomised controlled trials. Int Dent J 2014; 64: 34-45. https://doi.org/10.1111/idj.12060
  10. Vilchez-Perez MA, Sancho-Puchades M, Valmaseda-Castellon E, Paredes-Garcia J, Berini-Aytes L, Gay-Escoda C. A prospective, randomized, triple-blind comparison of articaine and bupivacaine for maxillary infiltrations. Med Oral Patol Oral Cir Bucal 2012; 17: e325-30.
  11. Gross R, McCartney M, Reader A, Beck M. A Prospective, Randomized, Double-blind Comparison of Bupivacaine and Lidocaine for Maxillary Infiltrations. J Endod 2007; 33: 1021-4. https://doi.org/10.1016/j.joen.2007.06.003
  12. Sampaio RM, Carnaval TG, Lanfredi CB, Horliana AC, Rocha RG, Tortamano IP. Comparison of the anesthetic efficacy between bupivacaine and lidocaine in patients with irreversible pulpitis of mandibular molar. J Endod 2012; 38: 594-7. https://doi.org/10.1016/j.joen.2012.01.008
  13. Brajkovic D, Biocanin V, Milic M, Vucetic M, Petrovic R, Brkovic B. Quality of analgesia after lower third molar surgery: A randomised, double-blind study of levobupivacaine, bupivacaine and lidocaine with epinephrine. Vojnosanit Pregl 2015; 72: 50-6. https://doi.org/10.2298/VSP1501050B
  14. Nespeca JA. Clinical trials with bupivacaine in oral surgery. Oral Surg Oral Med Oral Pathol 1976; 42: 301-7. https://doi.org/10.1016/0030-4220(76)90163-8
  15. Balakrishnan K, Ebenezer V, Dakir A, Kumar S, Prakash D. Bupivacaine versus lignocaine as the choice of local anesthetic agent for impacted third molar surgery a review. J Pharm Bioallied Sci 2015; 7: S230-3. https://doi.org/10.4103/0975-7406.160035
  16. Moore PA. Bupivacaine: A long-lasting local anesthetic for dentistry. Oral Surg Oral Med Oral Pathol 1984; 58: 369-74. https://doi.org/10.1016/0030-4220(84)90325-6
  17. de Souza AM, Horliana AC, Simone JL, Jorge WA, Tortamano IP. Postoperative pain after bupivacaine supplementation in mandibular third molar surgery: split-mouth randomized double blind controlled clinical trial. Oral Maxillofac Surg 2014; 18: 387-91. https://doi.org/10.1007/s10006-014-0471-4
  18. Fox MG, Patrie JT. Does Reducing the Concentration of Bupivacaine When Performing Therapeutic Shoulder Joint Injections Impact the Clinical Outcome? AJR Am J Roentgenol 2016; 206: 805-9. https://doi.org/10.2214/AJR.15.15132
  19. Iamaroon A, Tangwiwat S, Sirivanasandha B, Halilamien P, Lertpenmetha Y, Sirimaneewattana S, et al. Femoral nerve block using 0.25% or 0.5% bupivacaine for analgesia after arthroscopic anterior cruciate ligament reconstruction. J Med Assoc Thai 2014; 97: 717-23.
  20. Palma A, Viegas J, Manlhiot C, McCrindle B, Benson L. Use of local anesthetic (0.25% bupivacaine) for pain control after pediatric cardiac catheterization: A randomized controlled trial. Catheter Cardiovasc Interv 2016; 87: 318-23. https://doi.org/10.1002/ccd.26284
  21. de Lima E Souza R, Correa CH, Henriques MD, de Oliveira CB, Nunes TA, Gomez RS. Single-injection femoral nerve block with 0.25% ropivacaine or 0.25% bupivacaine for postoperative analgesia after total knee replacement or anterior cruciate ligament reconstruction. J Clin Anesth 2008; 20: 521-7. https://doi.org/10.1016/j.jclinane.2008.05.016
  22. Mulroy MF, Larkin KL, Batra MS, Hodgson PS, Owens BD. Femoral nerve block with 0.25% or 0.5% bupivacaine improves postoperative analgesia following outpatient arthroscopic anterior cruciate ligament repair. Reg Anesth Pain Med 2001; 26: 24-9. https://doi.org/10.1097/00115550-200101000-00007
  23. Bouloux GF, Punnia-Moorthy A. Bupivacaine versus lidocaine for third molar surgery: a double-blind, randomized, crossover study. J Oral Maxillofac Surg 1999; 57: 510-4. https://doi.org/10.1016/S0278-2391(99)90063-0
  24. Nielsen TH, Kristoffersen E, Olsen KH, Larsen HV, Husegaard HC, Wernberg M. Plain bupivacaine: 0.5% or 0.25% for spinal analgesia? Br J Anaesth 1989; 62: 164-7. https://doi.org/10.1093/bja/62.2.164
  25. Lyons GR, Kocarev MG, Wilson RC, Columb MO. A comparison of minimum local anesthetic volumes and doses of epidural bupivacaine (0.125% w/v and 0.25% w/v) for analgesia in labor. Anesth Analg 2007; 104: 412-5. https://doi.org/10.1213/01.ane.0000252458.20912.ef
  26. Dhanrajani P and Chung P. Comparative study of analgesia with bupivacaine 0.25% versus 0.5% for third molar removal under general anesthesia. J Dent Anesth Pain Med 2016; 16: 117-22. https://doi.org/10.17245/jdapm.2016.16.2.117
  27. Kaya Z, Suren M, Arici S, Karaman S, Tapar H, Erdemir F. Prospective, randomized, double-blinded comparison of the effects of caudally administered levobupivacaine 0.25% and bupivacaine 0.25% on pain and motor block in children undergoing circumcision surgery. Eur Rev Med Pharmacol Sci 2012; 16: 2014-20.